雌激素为何重要:评估GnRH拮抗剂并考虑加回疗法的系统性综述与Meta分析
本系统性综述与Meta分析纳入7项随机对照试验,评估口服GnRH拮抗剂(50-200mg,每日1或2次)治疗子宫内膜异位症相关疼痛的安全性与有效性,伴或不伴加回疗法。最低剂量组痛经和非月经性盆腔痛评分较基线下降显著大于安慰剂组,但不良事件率与缓解率正相关;近期文献建议联合加回疗法以减轻低雌激素效应并允许长期使用。
要点
- 最低剂量GnRH拮抗剂组痛经和非月经性盆腔痛评分下降显著大于安慰剂组。
- 缓解率与不良事件率呈正相关,符合剂量-反应效应。
- 近期文献建议GnRH拮抗剂联合加回疗法,以减轻低雌激素效应并维持疗效。
核心结论
- GnRH拮抗剂可减少子宫内膜异位症相关疼痛,但低雌激素效应限制长期使用;加回疗法可能消除该不良反应。
研究设计与样本
- 系统性综述与Meta分析,初筛345项研究后纳入7项随机对照试验,比较不同口服GnRH拮抗剂剂量(最低50mg至最高200mg,每日1或2次)。
主要发现
- 最低剂量GnRH拮抗剂组痛经疼痛评分较基线下降显著大于安慰剂组(OR -13.12,95% CI -17.35至-8.89)。
- 最低剂量GnRH拮抗剂组非月经性盆腔痛评分较基线下降显著大于安慰剂组(OR -3.08,95% CI -4.39至-1.76)。
- 缓解率与不良事件率呈正相关,符合剂量-反应效应。
临床怎么用
- 近期文献建议使用GnRH拮抗剂联合加回疗法,以减轻低雌激素效应、维持疗效并允许长期使用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gonadotrophin-releasing hormone (GnRH) antagonists have been demonstrated to reduce endometriosis-associated pain. Because of the hypo-oestrogenic state they induce, however, higher dosages of GnRH antagonists are not recommended for used long term. This unwanted effect may be eliminated by so-called add-back therapy (ABT). This review was conducted to assess the safety and efficacy of GnRH antagonists, with or without add-back hormonal replacement therapy. Out of the 345 studies selected through the initial search, seven randomized controlled trials were included, comparing different oral GnRH antagonists at varying dosages, from a minimum of 50 mg to a maximum of 200 mg once or twice daily. Women treated with the lowest dose of GnRH antagonists had significantly greater mean pain score reductions from baseline throughout treatment compared with those treated with placebo (odds ratio [OR] -13.12, 95% CI -17.35 to -8.89 and OR -3.08, 95% CI -4.39 to -1.76 for dysmenorrhoea and non-menstrual pelvic pain, respectively). Compatible with the dose-response effect, a positive correlation was found between response rates and adverse event rates. While GnRH antagonists offer an advantage in terms of pain reduction for endometriosis, the more recent literature suggests using GnRH antagonists with ABT, which, while mitigating the hypo-oestrogenic effects of GnRH antagonists, maintain their efficacy, while allowing their long-term use.
引用
- Viviano M, Benagiano G, Guo SW, et al. Why do oestrogens matter: systematic review and meta-analysis assessing GnRH antagonists, considering add-back therapy, for endometriosis-associated pain. Reprod Biomed Online. 2024. PMID: 39098266. doi:10.1016/j.rbmo.2024.104321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。